← Back to Search

Observational for Thyroid Cancer

N/A
Recruiting
Led By Azra Alizad, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months post ablation, 6 months post ablation, 12 months post ablation
Awards & highlights

Study Summary

This study is being done to identify and differentiate thyroid nodules by acoustic imaging and viscoelastic parameters.

Eligible Conditions
  • Thyroid Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months post ablation, 6 months post ablation, 12 months post ablation
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months post ablation, 6 months post ablation, 12 months post ablation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of nodules successfully sited by vibro-acoustography (VA)
Specificity of VA in differentiating malignant and benign of thyroid nodules

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo ultrasound imaging on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,134 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,503 Total Patients Enrolled
Azra Alizad, M.D.Principal InvestigatorMayo Clinic in Rochester
2 Previous Clinical Trials
666 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~99 spots leftby Dec 2026